Cubist Pharmaceuticals, Inc. Increases Revenue 18% to $238 Million in the Third Quarter

October 19, 2012 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced results for the third quarter ended September 30, 2012. The Company will host a conference call and webcast today at 5:00 p.m. ET (details below).

Twitter
LinkedIn
Facebook
Email
Print

Earnings